Understanding selective trafficking of lymphocyte subsets.
Heydtmann
M
M
Liver Research Laboratories, MRC Centre for Immune Regulation, University of Birmingham Institute for Clinical Science, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH.
Adams
D H
DH
D000917:Antibody Formation / Q000276:immunology; D000075743:Chemokine CXCL16; D018925:Chemokines / Q000276:immunology*; D019743:Chemokines, CXC / Q000276:immunology; D006801:Humans; D008213:Lymphocyte Activation; D008565:Membrane Proteins / Q000276:immunology; D000075744:Receptors, CXCR6; D019707:Receptors, Chemokine / Q000276:immunology; D018121:Receptors, Cytokine / Q000276:immunology; D043562:Receptors, G-Protein-Coupled; D011971:Receptors, Immunologic; D051116:Receptors, Scavenger; D011991:Receptors, Virus; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology
C423727:CXCL16 protein, human; C106330:CXCR6 protein, human; D000075743:Chemokine CXCL16; D018925:Chemokines; D019743:Chemokines, CXC; D008565:Membrane Proteins; D000075744:Receptors, CXCR6; D019707:Receptors, Chemokine; D018121:Receptors, Cytokine; D043562:Receptors, G-Protein-Coupled; D011971:Receptors, Immunologic; D051116:Receptors, Scavenger; D011991:Receptors, Virus